ADVENZYMESAdvanced Enzyme Technologies Ltd.

    Advanced Enzyme Technologies Ltd: news and announcements

    Every Advanced Enzyme Technologies Ltd filing with the NSE and BSE that Blacklitt has written about, explained in plain words and linked to the filing, newest first: corporate action, capital raise.

    9 articles · enzymes and biotechnology · Latest 30 Oct 2026

    A technician in a white coat working at laboratory glassware, in an old black-and-white photograph

    ADVENZYMESAdvanced Enzyme Technologies Ltd

    Advanced Enzyme Technologies Buys Back 55,794 Shares on 19 Oct, Total Reaches 20.86 Lakh

    Advanced Enzyme Technologies Limited has filed its daily buyback report for 19 Oct 2026 for its open-market buyback of equity shares of face value ₹2. On that day it bought back 55,794 shares on NSE through Emkay Global Financial Services Limited, at an average price of ₹267.60 a share excluding transaction costs.

    • Corporate action
    • Biotechnology

    Blacklitt Research1 min read

    ADVENZYMESAdvanced Enzyme Technologies Ltd

    Advanced Enzyme Technologies buys back 49,647 shares on 15 Oct, taking its total past 20 lakh

    Advanced Enzyme Technologies Limited has filed its daily report for its open-market share buyback for 15 Oct 2026. On that day it bought back 49,647 equity shares of face value ₹2 each, all on NSE, through Emkay Global Financial Services Limited, at an average price of ₹269.0964 per share, excluding transaction costs.

    • Corporate action

    Blacklitt Research1 min read

    Two glass laboratory flasks standing in cork rings

    ADVENZYMESAdvanced Enzyme Technologies Ltd

    Advanced Enzyme Technologies buys back 46,178 shares on 13 Oct, taking its total to 19.14 lakh

    Advanced Enzyme Technologies Limited has filed its daily report for its open-market share buyback for 13 Oct 2026. On that day it bought back 46,178 equity shares of face value ₹2 each, all on NSE, through Emkay Global Financial Services Limited, at an average price of ₹266.8579 per share, excluding transaction costs.

    • Corporate action

    Blacklitt Research1 min read